2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium

C46H54IrN7-5 — CID 155636954

IUPAC2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium
SMILESCC1=C(C)N(c2[c-]cc(C(C)C)cc2)[CH-]N1CCCCN1[CH-]N(c2[c-]cc(C(C)C)cc2)C(C)=C1C.Cc1nc2c(-c3[c-]cccc3)nccn2c1C.[Ir]
InChIInChI=1S/C32H42N4.C14H12N3.Ir/c1-23(2)29-11-15-31(16-12-29)35-21-33(25(5)27(35)7)19-9-10-20-34-22-36(28(8)26(34)6)32-17-13-30(14-18-32)24(3)4;1-10-11(2)17-9-8-15-13(14(17)16-10)12-6-4-3-5-7-12;/h11-15,17,21-24H,9-10,19-20H2,1-8H3;3-6,8-9H,1-2H3;/q-4;-1;
InChIKeyRYCQDSQLERROTP-UHFFFAOYSA-N
MW897.20 g/mol
LogP10.81
Rot. Bonds10

About 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium

2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium (PubChem CID 155636954) has the molecular formula C46H54IrN7-5 and a molecular weight of 897.20 g/mol. Its IUPAC name is 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium.

Molecular Properties

Compound Name2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium
PubChem CID155636954
Molecular FormulaC46H54IrN7-5
Molecular Weight897.20 g/mol
Exact Mass897.41
IUPAC Name2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium
SMILESCC1=C(C)N(c2[c-]cc(C(C)C)cc2)[CH-]N1CCCCN1[CH-]N(c2[c-]cc(C(C)C)cc2)C(C)=C1C.Cc1nc2c(-c3[c-]cccc3)nccn2c1C.[Ir]
InChIInChI=1S/C32H42N4.C14H12N3.Ir/c1-23(2)29-11-15-31(16-12-29)35-21-33(25(5)27(35)7)19-9-10-20-34-22-36(28(8)26(34)6)32-17-13-30(14-18-32)24(3)4;1-10-11(2)17-9-8-15-13(14(17)16-10)12-6-4-3-5-7-12;/h11-15,17,21-24H,9-10,19-20H2,1-8H3;3-6,8-9H,1-2H3;/q-4;-1;
InChIKeyRYCQDSQLERROTP-UHFFFAOYSA-N
XLogP10.81
TPSA43.15 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds10
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500897.20
LogP ≤ 510.81
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium?
The IUPAC name of 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium (CID 155636954) is 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium.
What is the SMILES notation for 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium?
The canonical SMILES for 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium is CC1=C(C)N(c2[c-]cc(C(C)C)cc2)[CH-]N1CCCCN1[CH-]N(c2[c-]cc(C(C)C)cc2)C(C)=C1C.Cc1nc2c(-c3[c-]cccc3)nccn2c1C.[Ir].
What is the InChIKey of 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium?
The InChIKey is RYCQDSQLERROTP-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H42N4.C14H12N3.Ir/c1-23(2)29-11-15-31(16-12-29)35-21-33(25(5)27(35)7)19-9-10-20-34-22-36(28(8)26(34)6)32-17-13-30(14-18-32)24(3)4;1-10-11(2)17-9-8-15-13(14(17)16-10)12-6-4-3-5-7-12;/h11-15,17,21-24H,9-10,19-20H2,1-8H3;3-6,8-9H,1-2H3;/q-4;-1;.
What are the key properties of 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium?
2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium has a molecular weight of 897.20 g/mol, XLogP of 10.81, 10 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium is sourced from PubChem (CID 155636954), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).